Notice NOT-OD-20-162 from the NIH Guide for Grants and Contracts

Notice NOT-MD-20-026 from the NIH Guide for Grants and Contracts

Notice NOT-AI-20-067 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-090 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-099 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-098 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-158 from the NIH Guide for Grants and Contracts

Notice NOT-NS-20-097 from the NIH Guide for Grants and Contracts

Notice NOT-DA-21-056 from the NIH Guide for Grants and Contracts

Notice NOT-GM-20-051 from the NIH Guide for Grants and Contracts

Notice NOT-AA-20-018 from the NIH Guide for Grants and Contracts

Competitive: Charles River: For 70 years, Charles River employees have worked together to assist in the discovery, d Somerset, England

Competitive: Charles River: For 70 years, Charles River employees have worked together to assist in the discovery, d Massachusetts (US)

Notice NOT-NS-20-084 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-264 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research on the biology of high confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular and circuit substrates of neural function. For the purposes of this FOA, the term complex can refer to a multifactorial contribution to risk (e.g., polygenic and/or environmental) and/or highly distributed functional features of the brain disorder. Studies may be either hypothesis-generating (unbiased discovery) or hypothesis-testing in design and may utilize in vivo, in situ, or in vitro experimental paradigms, e.g., model organisms or human cell-based assays. While behavioral paradigms and outcome measures can be incorporated into the research design to facilitate the characterization of intracellular, transcellular and circuit mechanisms, these are neither required nor expected. Studies should not attempt to model disorders but instead should aim to elucidate the neurobiological impact of individual or combined risk factor(s), such as the affected molecular and cellular components and their relationships within defined biological process(es). This can include the fundamental biology of these factors, components and processes. The resulting paradigms, component pathways and biological processes should be disseminated with sufficient detail to enrich common and/or federated data resources (e.g., those contributing to the Gene Ontology, Synaptic Gene Ontology, FAIR Data Informatics) in order to bridge the gap between disease risk factors, biological mechanism and therapeutic target identification. The present announcement seeks R21 applications for high risk or early stage exploratory research.

Funding Opportunity PAR-20-263 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research on the biology of high confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular and circuit substrates of neural function. For the purposes of this FOA, the term complex can refer to a multifactorial contribution to risk (e.g., polygenic and/or environmental) and/or highly distributed functional features of the brain disorder. Studies may be either hypothesis-generating (unbiased discovery) or hypothesis-testing in design and may utilize in vivo, in situ or in vitro experimental paradigms, e.g., model organisms or human cell-based assays. While behavioral paradigms and outcome measures can be incorporated into the research design to facilitate the characterization of intracellular, transcellular and circuit mechanisms, these are neither required nor expected. Studies should not attempt to model disorders but instead should aim to elucidate the neurobiological impact of individual or combined risk factor(s), such as the affected molecular and cellular components and their relationships within defined biological process(es). This can include the fundamental biology of these factors, components and processes. The resulting paradigms, component pathways and biological processes should be disseminated with sufficient detail to enrich common and/or federated data resources (e.g., those contributing to the Gene Ontology, Synaptic Gene Ontology, FAIR Data Informatics) in order to bridge the gap between disease risk factors, biological mechanism and therapeutic target identification. The present announcement seeks R01 applications.

Competitive: CK Group: CK Clinical are recruiting for a Junior Statistician to join an innovative medical device company at their site based in Stirling, Scotland on a permanent... Stirling

Competitive: Charles River: For 70 years, Charles River employees have worked together to assist in the discovery, d Michigan (US)

Funding Opportunity RFA-MH-20-600 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits applications to develop web-accessible data archives to capture, store, and curate data related to BRAIN Initiative activities. The data archives will work with the research community to incorporate tools that allow users to analyze and visualize the data, but the creation of such tools is not part of this FOA. The data archives will use appropriate standards to describe the data, but the creation of such standards is not part of this FOA. A goal of this program is to advance research by creating a community resource data archive with appropriate standards and summary information that is broadly available and accessible to the research community for furthering research.

Notice NOT-MH-20-073 from the NIH Guide for Grants and Contracts